Theoretical and practical aspects of paclitaxel scheduling
- 1 November 1995
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 6 (9) , 861-863
- https://doi.org/10.1093/oxfordjournals.annonc.a059349
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Multi-day fractionated administration schedule for paclitaxelAnnals of Oncology, 1995
- Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.Journal of Clinical Oncology, 1995
- Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Paclitaxel administered by 1-hour infusion. Preliminary results of a phase 1/11 trial comparing two schedulesCancer, 1994
- The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell linesCancer Chemotherapy and Pharmacology, 1994
- Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell linesBritish Journal of Cancer, 1993
- Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.Journal of Clinical Oncology, 1993
- Taxol administered as a 120 hour infusionInvestigational New Drugs, 1992
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990